James B Cutrell

3.3k total citations · 1 hit paper
31 papers, 2.1k citations indexed

About

James B Cutrell is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, James B Cutrell has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Emergency Medicine. Recurrent topics in James B Cutrell's work include HIV/AIDS drug development and treatment (5 papers), Antibiotic Use and Resistance (5 papers) and HIV-related health complications and treatments (4 papers). James B Cutrell is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Antibiotic Use and Resistance (5 papers) and HIV-related health complications and treatments (4 papers). James B Cutrell collaborates with scholars based in United States, Canada and Tanzania. James B Cutrell's co-authors include Tomasz Z. Jodlowski, James M. Sanders, Marguerite L. Monogue, Roger Bedimo, Roger Bedimo, Henning Drechsler, Pablo Tebas, Naim M. Maalouf, Mark H. Drazner and Amit Khera and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

James B Cutrell

29 papers receiving 2.0k citations

Hit Papers

Pharmacologic Treatments for Coronavirus Disease 2019 (CO... 2020 2026 2022 2024 2020 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James B Cutrell United States 11 1.4k 519 209 193 167 31 2.1k
Haiyan Li China 15 1.5k 1.0× 549 1.1× 352 1.7× 183 0.9× 143 0.9× 76 2.6k
Tomasz Z. Jodlowski United States 10 1.3k 0.9× 507 1.0× 201 1.0× 220 1.1× 151 0.9× 21 1.9k
Ritu Singh India 21 1.7k 1.2× 524 1.0× 300 1.4× 352 1.8× 204 1.2× 61 2.9k
Cheng Cui China 10 1.5k 1.0× 549 1.1× 308 1.5× 164 0.8× 127 0.8× 44 2.2k
Xueting Yao China 10 1.5k 1.0× 551 1.1× 324 1.6× 161 0.8× 147 0.9× 38 2.2k
Marguerite L. Monogue United States 18 1.3k 0.9× 507 1.0× 283 1.4× 344 1.8× 152 0.9× 40 2.4k
Zhongsi Hong China 15 1.9k 1.4× 467 0.9× 440 2.1× 152 0.8× 174 1.0× 30 2.5k
Yu Min Kang South Korea 13 929 0.6× 403 0.8× 108 0.5× 94 0.5× 127 0.8× 32 1.3k
Mariachiara Ippolito Italy 19 812 0.6× 313 0.6× 133 0.6× 219 1.1× 144 0.9× 69 1.9k

Countries citing papers authored by James B Cutrell

Since Specialization
Citations

This map shows the geographic impact of James B Cutrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B Cutrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B Cutrell more than expected).

Fields of papers citing papers by James B Cutrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B Cutrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B Cutrell. The network helps show where James B Cutrell may publish in the future.

Co-authorship network of co-authors of James B Cutrell

This figure shows the co-authorship network connecting the top 25 collaborators of James B Cutrell. A scholar is included among the top collaborators of James B Cutrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B Cutrell. James B Cutrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cutrell, James B & James M. Sanders. (2024). How Should Clinicians Navigate Interprofessional Tension in Their Roles as Antimicrobial Stewards?. The AMA Journal of Ethic. 26(6). E441–447. 1 indexed citations
2.
Anderson, S. Keith, et al.. (2024). Early Oral Step-Down Versus Continued Intravenous Antibiotic Treatment of Complicated Intra-Abdominal Infection. Surgical Infections. 25(10). 742–748.
3.
Cutrell, James B, et al.. (2023). PAs and NPs in employee health during the COVID-19 pandemic. JAAPA. 36(3). 42–45. 1 indexed citations
4.
Franzblau, Lauren E., et al.. (2023). Improving Access To Penicillin Allergy Testing Among Pregnant Patients In An Obstetrics Clinic. Journal of Allergy and Clinical Immunology. 151(2). AB58–AB58. 1 indexed citations
5.
Cawcutt, Kelly, Jasmine R Marcelin, Nicolás Cortés-Penfield, et al.. (2022). #SoMe the Money! Value, Strategy, and Implementation of Social Media Engagement for Infectious Diseases Trainees, Clinicians, and Divisions. Clinical Infectious Diseases. 74(Supplement_3). S229–S236. 6 indexed citations
6.
Wang, Jijia, et al.. (2022). Healthcare utilization and outcomes of spinal cord injured veterans with stage 3–4 pressure injuries. Journal of Spinal Cord Medicine. 47(3). 345–353. 3 indexed citations
7.
Phen, Samuel, et al.. (2021). Left hand necrosis as the initial presentation of disseminated mucormycosis: A case report and literature review. IDCases. 26. e01269–e01269. 1 indexed citations
8.
Yen, Christina & James B Cutrell. (2021). Antimicrobial ethicists: Making ethics explicit in antimicrobial stewardship. SHILAP Revista de lepidopterología. 1(1). e17–e17. 8 indexed citations
9.
Sabot, Oliver, Alejandro Llanos‐Cuentas, Ally Olotu, et al.. (2021). COVID-19 Therapeutics for Low- and Middle-Income Countries: A Review of Candidate Agents with Potential for Near-Term Use and Impact. American Journal of Tropical Medicine and Hygiene. 105(3). 584–595. 9 indexed citations
10.
Sanders, James M., et al.. (2021). Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?. Current Infectious Disease Reports. 23(12). 28–28. 4 indexed citations
11.
Drechsler, Henning, et al.. (2021). Consistent use of lipid lowering therapy in HIV infection is associated with low mortality. BMC Infectious Diseases. 21(1). 150–150. 5 indexed citations
12.
Smith, Winter J., et al.. (2021). Impact of a Rapid Blood Culture Diagnostic Panel on Time to Optimal Antimicrobial Therapy at a Veterans Affairs Medical Center. Journal of Pharmacy Practice. 35(5). 722–729. 10 indexed citations
13.
Kang, Minji, et al.. (2021). Influenza vaccination among healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic. Infection Control and Hospital Epidemiology. 43(9). 1303–1305. 2 indexed citations
14.
Cutrell, James B, Henning Drechsler, Roger Bedimo, Carlos A. Álvarez, & Ishak A. Mansi. (2019). Statin use and medically attended acute respiratory illness among influenza vaccine recipients. Vaccine. 37(44). 6707–6713. 4 indexed citations
15.
Drechsler, Henning, et al.. (2017). Current use of statins reduces risk of HIV rebound on suppressive HAART. PLoS ONE. 12(3). e0172175–e0172175. 10 indexed citations
16.
Cutrell, James B, Nicolas Barros, James P. Luby, et al.. (2016). Risk factors for deep sternal wound infection after cardiac surgery: Influence of red blood cell transfusions and chronic infection. American Journal of Infection Control. 44(11). 1302–1309. 26 indexed citations
17.
Bedimo, Roger, James B Cutrell, Song Zhang, et al.. (2015). Mechanisms of bone disease in HIV and hepatitis C virus. AIDS. 30(4). 601–608. 23 indexed citations
19.
Cutrell, James B, et al.. (2014). Surveillance of patients identified with fungal mold at a public academic medical center. American Journal of Infection Control. 42(7). 776–780. 2 indexed citations
20.
Cutrell, James B & Roger Bedimo. (2013). Non-AIDS-defining Cancers Among HIV-Infected Patients. Current HIV/AIDS Reports. 10(3). 207–216. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026